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Studies carried out in various populations have reported an association between some HLA specificities and
susceptibility to tuberculosis. We investigated the class I and class II HLA profile in Brazilian patients of various
ethnic backgrounds who had AIDS and tuberculosis. Twenty-two adult patients with AIDS and tuberculosis (Group
I), 103 patients with AIDS without tuberculosis (Group II) and 423 healthy individuals not infected with HIV (Group
III) were evaluated. Diagnosis of HIV infection was made by ELISA, confirmed by a gelatin particle agglutination
test. Diagnosis of tuberculosis was made based on clinical/radiological presentation and direct bacilloscopy or
clinical specimen cultures. Class I antigens were typed by microlymphotoxicity. Class II alleles were characterized
by the polymerase chain reaction (PCR). Differences in frequency of HLA specificities between groups were found
in the following antigens/alleles: Group I x Group II: HLA-A31 – p=0.026; HLA-B41 – p= 0.037; HLA-DRB1*10 –
p=0.037; HLA-DQB1*5 – p=0.009. Group I x Group III (control): HLA-A31 – p = 0.000008; odds ratio (OR)=31.75;
HLA-B41 – p=0.003; HLA-DQB1*5 – p=0.02. HLA-A31 and HLA-B41 antigens and the HLA-DRB1*10 and HLA-
DQB1*05 alleles were over-represented in patients with AIDS and tuberculosis (Group I), suggesting that these
HLA molecules are associated with susceptibility to tuberculosis in Brazilian patients with AIDS.
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Tuberculosis is an important public health problem in Brazil
and has been one of the most frequent infection complications
in patients with AIDS [1], because the integrity of the immune
response of the host is needed for control the course of this
disease. In addition, there is a relation between the
immunological response and the HLA profile of an individual,
which results in greater or lesser genetic susceptibility to
certain infections, such as tuberculosis [2-10].
Various HLA subtypes have been indicated individually
or as part of haplotypes as indicators of AIDS; almost all of
them confer susceptibility to, and some of them confer
protection against development of this disease [11-17].
In view of the fact that the Brazilian population consists
of different ethnic groups, our objective was to investigate
the Class I and Class II HLA profile in patients who had AIDS
and tuberculosis from the Ribeirão Preto region, SP. In this
region, the Caucasoid population is predominantly of
European origin and most black individuals are descendants
of the Bantu population [18].
Material and Methods
For analysis purposes, the patients were divided into three
groups. Group I consisted of 22 patients with tuberculosis
and AIDS, consisting of 15 males and seven females ranging
in age from 21 to 44 years (median = 33 years). The CD4+ cell
count for these patients ranged from 4 to 339 (median = 110)
and the logarithms of the viral load of human
immunodeficiency virus (HIV) ranged from 2.7 to 6.11 (median
= 4.94). Eighteen of these patients were under treatment with
highly active antiretroviral therapy (HAART).
Group II consisted of 103 individuals with AIDS, but without
tuberculosis; 66 of them were men, ranging in age from 21 to 59
years (median = 34 years). In this group the CD4+ cell count
ranged from 1 to 623 (median = 96) and the logarithms of the
HIV viral load ranged from 1.99 to 6.92 (median = 4.81). Seventy-
one of these patients were under treatment with HAART.
Group III, the population control, consisted of 423 healthy
non-HIV-infected individuals from the same geographic region
and of the same ethnic composition as Groups I and II. Among
these subjects, 257 served as controls in the study of class I
antigens and 166 in the investigation of class II alleles.
HIV infection was diagnosed by the ELISA method (Abbott
Recombinant HIV-1/HIV-2 IEA™), confirmed by a gelatin
particle agglutination test (Serodia™, Fujerebio Inc., Tokyo,
Japan). Tuberculosis was diagnosed on the basis of clinical/
radiological presentation and confirmed by direct bacilloscopy
and/or culture of biological specimens.
Class I HLA antigens were typed by classical serology,
with 66 specificities tested.
Sequence-specific primers (SSP, Opels, Heildeberg,
Germany) hybridized with DNA amplified by the polymerase
chain reaction were used for class II HLA allele typing (HLA-
DRB1* and HLA-DQB1*), using commercial kits (OneLambda,
Canoga Park, CA, USA), for a total of 21 specificities. The
association between HLA profile and diseases was
investigated according to Svejgaard &Ryder (1994) [19].
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Probability values (p) were obtained by the chi-square
(χ2) test with Yates correction or by the two-tailed Fisher exact
test, with the level of significance set at p ≤ 0.05 (95%
confidence interval). When the differences between groups
were significant (p ≤ 0.05), the odds ratio (OR) was also
calculated.
Results
Table 1 lists the antigen and allele frequencies that were
significantly different between groups.
Analysis of Table 1 shows that HLA-A31 and HLA-B41
antigens were over-represented in the TB group (Group I x
Group II: p=0.028 and 0.0039, respectively; Group I x Group III:
p=0.001 and 0.0039, respectively). Allele HLA-BRB1*10 was
over-represented in patients with TB and AIDS, compared with
AIDS patients without TB (p=0.0039), and allele HLA-DQB1*05
was also over-represented in the TB group, in all comparisons
(Group I x Group II: p=0.0001; Group I x Group III: p=0.018).
Discussion
Vijaya Lakshimi et al. (2006) [8], in a study of the association
of class I molecules (HLA-B) in patients with pulmonary
tuberculosis who also had AIDS, or not, detected an
association of HLA-B52(5) with protection against, and of
HLA-B51(5) with susceptibility to tuberculosis, regardless of
whether the patient was HIV-infected or not.
Also, in an investigation of class I HLA subtypes, Soto et
al. (2007) [10], in a study on Mexican patients, demonstrated
an association of HLA-B35 with pulmonary tuberculosis and
of HLA B39 and HLA B40 with extrapulmonary tuberculosis,
and Pospelov et al. (2007) [9], in a study of Russian patients,
detected a positive association of HLA-B27 antigen with
tuberculosis.
In our study (Table 1), the HLA-A31 and HLA-B41 antigens
were more frequent in the group of patients with AIDS and
of São Paulo [17]. We also found that the presence of the HLA-
A31 antigen was associated with tuberculosis in patients with
AIDS in the present study. When the patients with AIDS, but
without tuberculosis (Group II), were compared with the
population control, the HLA-A31 antigen was also more
frequent in the population with AIDS (p=0.001; OR=8.11;
CI=1.96-38.65).
Several studies conducted on different populations have
also demonstrated an association of some class II alleles with
tuberculosis. The haplotypes DRB1*1601, DQB1*0502 alleles
and DQB1*1601-DQB1*0502, DRB1*04-DQB1*03, DRB1*14-
DQB1*5 have been found to be related to a higher risk of
developing tuberculosis, whereas a low frequency of the
DQB1*0201 allele and of the DRB1*11-DQB1*03 haplotype
was found to be associated with tuberculosis in Polish patients
[7,20]. Similarly, Kim et al. (2005) [21] demonstrated that the
DRB1*0803 and DQB1*0601 alleles were associated with the
progression of tuberculosis in Korean patients, and Pospelov
et al. (2007) [9] reported an association of HLA-DRB1 13 (6)
and HLA-DRB1 14 (6) with this disease.
In our study, the HLA-DRB1*10 and HLA-DQB1*05 alleles
were also more frequent in the group of patients with AIDS
and tuberculosis compared to the group of patients with AIDS,
but without tuberculosis (p=0.0039; OR=20.32; IC=3.17-127,95;
and p=0.0001; OR=12.30; CI=4.78-31.64, respectively).
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tuberculosis compared to the patients with AIDS but without
tuberculosis (p=0.028; OR=3.83; CI=1.20-12.24; and p=0.0039;
OR=20.32; CI=3.16-127.95, respectively). Similarly, the HLA-A31
and HLA-B41 antigens were more frequent in the population
with AIDS and tuberculosis compared to the population controls
(p=0.0001; OR=20.37; CI=4.64-89.35; and p=0.0039; OR=20.32;
CI=3.16-127.95, respectively).
A previous study conducted at the same institution
demonstrated that the HLA-A31 antigen is strongly associated
with AIDS in patients from the northeastern region of the state
Table 1. Class I and II antigens and alleles that differed in frequency between groups with AIDS and tuberculosis (TB).
Antigens/ AIDS and TB AIDS Controls Group I Group I Group II
alleles (Group I) (Group II) (Group III) x x x
N=22 N=103 Class I Class II Group II Group III Group III
N=257 N=166
N % N % N % N %
HLA-A31 6 27.3 9 8.7 3 1.2 - - p=0.028 p=0.0001 p=0.001
OR=3.83 OR=20.37 OR=8.11
HLA-B41 3 13.6 2 1.9 2 0.8 - - p=0.0039 p=0.0039 NS
OR=20.32 OR=20.32
HLA- 3 13.6 2 1.9 - - 6 3.6 p=0.0039 p=0.073 NS
DRB1*10 OR=20.32
HLA- 14 63.6 32 31.0 - - 59 35.5 p=0.0001 p=0.018 NS
DQB1*05 OR=12.30 OR=3.17
NS=not significant; OR=odds ratio.
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When patients with AIDS and tuberculosis were compared
to the population control, the DQB1*05 allele was also found
to be more frequent among patients (p=0.018; OR=3.17;
CI=1.25-8.00). We suggest that the HLA-A31 and HLA-B41
antigens and the HLA-DRB1*10 and HLA-DQB1*05 alleles
are associated with susceptibility to tuberculosis in patients
with AIDS from the northeast region of the state of São Paulo.
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